manidipine has been researched along with benidipine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidekazu, H; Koji, H; Masanori, S; Mitsuharu, H; Shigefumi, S; Takanobu, A; Takeshi, I; Toshihiko, S; Yasuyuki, B | 1 |
| Hamada, C; Hosaka, S; Kitamori, N; Sadoshima, T; Sato, M; Takahashi, Y | 1 |
| Bisenieks, E; Duburs, G; Gall Troselj, K; Krauze, A; Poikans, J; Velena, A; Zarkovic, N | 1 |
| Choi, DK; Kim, DK; Kim, JH; Kim, JW; Kwon, OB; Lee, DS; Lee, H; Lee, J; Lee, S; Min, SH; Yu, JH | 1 |
1 review(s) available for manidipine and benidipine
| Article | Year |
|---|---|
1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.
Topics: Amlodipine; Animals; Antioxidants; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cattle; Dihydropyridines; Epithelial Cells; Humans; Hydrogen; Lipoproteins, LDL; Mice; Microsomes; Mitochondria; Niacinamide; Nifedipine; Nitrobenzenes; Oxidants; Oxidative Stress; Piperazines | 2016 |
3 other study(ies) available for manidipine and benidipine
| Article | Year |
|---|---|
Orally administered benidipine and manidipine prevent ischemia-reperfusion injury in the rat heart.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Creatine Kinase; Dihydropyridines; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrobenzenes; Piperazines; Rats; Rats, Wistar; Vasodilator Agents; Ventricular Function, Left | 2004 |
Effects of compression on the interaction between 1,4-dihydropyridine compounds and lactose monohydrate (II): differences in powder properties of 1,4-dihydropyridine compounds.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dihydropyridines; Lactose; Nitrobenzenes; Particle Size; Piperazines; Powders; Pressure; Tablets; Temperature | 2007 |
Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.
Topics: Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Calcium Channels; Carcinoma, Ovarian Epithelial; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dihydropyridines; Drug Repositioning; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Nitrobenzenes; Ovarian Neoplasms; Paclitaxel; Piperazines; Signal Transduction; Tumor Microenvironment | 2020 |